Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

Contrarian investing advice from biotech and pharmaceutical stock expert Hartaj Singh, Founding Partner of Tecumseh Partners ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Once viewed as a stable but slow-growth sector, healthcare is now a magnet for venture capital, private equity, and institutional investors. To understand this shift, we spoke with Dmitrii Khasanov, ...

Victor Li, Chairman of CKLIFE SCIENCES (00775.HK), was asked about his views on the company's prospects after the ...

Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...

Eikon Therapeutics announces layoffs, cutting 55 jobs due to reduced federal funding and biotech investment challenges.

The US’s policy under the Second Donald Trump Administration has undergone major changes, with experts saying that America is ...

In 2025, the global proteose peptone market is anticipated to be worth USD 151.4 million, with projections indicating a rise ...

3SBio's shares surged 32% to 19.18 Hong Kong dollars, equivalent to US$2.45, on Tuesday after the Chinese company said it would receive an upfront payment of US$1.25 billion and potential milestone ...

The Greater Baltimore Committee’s latest investment summit captured the optimism of an ecosystem bolstered by big private employers, startups, universities, government and beyond.